Palisade Bio, Inc. (PALI) SEC Filings — 2024

Filings

• Palisade Bio Announces Material Agreement and Equity Sales — 8-K · Dec 16, 2024
• Palisade Bio Files S-1/A Amendment — S-1/A · Dec 9, 2024
• Palisade Bio Files S-1/A Amendment — S-1/A · Dec 5, 2024
• Palisade Bio Files S-1/A Amendment — S-1/A · Nov 21, 2024
• Palisade Bio, Inc. SC 13G Filing — SC 13G · Nov 14, 2024
• Palisade Bio Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
• Palisade Bio Files S-1 for Potential Securities Offering — S-1 · Oct 30, 2024
• Palisade Bio Appoints New CEO — 8-K · Sep 27, 2024
• Palisade Bio Files Q2 2024 10-Q, Details Stock Activity — 10-Q · Aug 12, 2024
• Palisade Bio Files 8-K on Security Holder Vote — 8-K · Jul 8, 2024
• Palisade Bio Files Definitive Proxy Statement — DEF 14A · May 22, 2024
• Palisade Bio, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
• Palisade Bio Appoints New CMO and CSO — 8-K · May 10, 2024
• Palisade Bio Secures $1.5M Convertible Note Financing — 8-K · May 3, 2024
• Palisade Bio Files 8-K Report — 8-K · Apr 10, 2024
• Palisade Bio Relocates Principal Offices — 8-K · Apr 5, 2024
• Palisade Bio Faces Nasdaq Delisting Warning — 8-K · Mar 27, 2024
• Palisade Bio Files 2023 10-K, Details Warrant Activity — 10-K · Mar 26, 2024
• Palisade Bio Appoints Dr. Jonathan T. Hunt as CEO — 8-K · Mar 6, 2024
• Palisade Bio, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Palisade Bio Reports Officer/Director Changes in 8-K — 8-K · Feb 13, 2024
• Palisade Bio, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• L1 Capital Amends Palisade Bio Stake, Signals Portfolio Shift — SC 13G/A · Feb 9, 2024
• Intracoastal Capital Amends Palisade Bio Stake on Dec 31, 2023 — SC 13G/A · Feb 6, 2024
• Palisade Bio, Inc. Announces Special Meeting of Stockholders to Vote on Reverse Stock Split — DEF 14A · Feb 6, 2024
• PALISADE BIO Sells Equity in Unregistered Offering — 8-K · Feb 1, 2024
• PALISADE BIO Files 8-K for Regulation FD Disclosure — 8-K · Jan 29, 2024